These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 13307722)

  • 21. The nephrotic syndrome and chronic hypotension associated with primary systemic amyloidosis; report of a case.
    SCHNECKLOTH RE; PAGE IH
    Am J Med Sci; 1955 Sep; 230(3):299-304. PubMed ID: 13248864
    [No Abstract]   [Full Text] [Related]  

  • 22. Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory?
    Keane WF; St Peter JV; Kasiske BL
    Kidney Int Suppl; 1992 Oct; 38():S134-41. PubMed ID: 1405364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Disturbances of lipid metabolism during nephrotic syndrome: physiopathology and treatment].
    Moulin B; Ollier J; Olmer M
    Nephrologie; 1992; 13(5):193-9. PubMed ID: 1470293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Glomerulonephritis with nephrotic syndrome, bilateral segmental stenosis purpural ureteritis and anuria].
    MIDON J; SOMMELET J; LAMY P; LARCAN A
    J Urol Medicale Chir; 1955; 61(10-11):737-40. PubMed ID: 13332727
    [No Abstract]   [Full Text] [Related]  

  • 25. Mechanisms of hyperlipemia in experimental nephrosis.
    SAFFRAN J; KALANT N
    J Clin Invest; 1959 Oct; 38(10 Pt 1-2):1717-24. PubMed ID: 14440744
    [No Abstract]   [Full Text] [Related]  

  • 26. Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome.
    Kaysen GA; Davies RW
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S75-9. PubMed ID: 16989070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of pravastatin on serum lipids and apolipoproteins in hyperlipidemia of the nephrotic syndrome.
    Tokoo M; Oguchi H; Terashima M; Tokunaga S; Miyasaka M; Hora K; Higuchi M; Yoshie T; Furuta S
    Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):397-403. PubMed ID: 1635284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lowering effect of probucol on plasma lipoprotein and proteinuria in puromycin aminonucleoside-induced nephrotic rats.
    Hirano T; Mamo JC; Nagano S; Sugisaki T
    Nephron; 1991; 58(1):95-100. PubMed ID: 1857487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal microdissection in infants with special reference to the congenital nephrotic syndrome.
    PAATELA M
    Ann Paediatr Fenn; 1963; 9(Suppl 21)():1-57. PubMed ID: 13940922
    [No Abstract]   [Full Text] [Related]  

  • 30. [Nephrotic syndrome in disseminated lupus erythematosus; result of the use of ion exchange resins].
    KAMINSKY A; KAPLAN H; SCHAPIRA L
    Dia Med; 1955 Sep; 27(62):2002-3. PubMed ID: 13261855
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of ethionine on blood and depot lipids in experimental nephrotic hyperlipemia.
    HEYMANN W; HACKEL DB
    Proc Soc Exp Biol Med; 1956 May; 92(1):41-3. PubMed ID: 13336067
    [No Abstract]   [Full Text] [Related]  

  • 32. Relationships between blood lipid and blood protein levels in the nephrotic syndrome.
    THOMAS EM; ROSENBLUM AH; LANDER HB; FISHER R
    AMA Am J Dis Child; 1951 Feb; 81(2):207-14. PubMed ID: 14798961
    [No Abstract]   [Full Text] [Related]  

  • 33. Observations on the hyperlipemia of experimental nephrosis in rats. The effect of urinary proteins.
    TRACY RE; WISSLER RW
    Lab Invest; 1962 Jan; 2():1-13. PubMed ID: 13922235
    [No Abstract]   [Full Text] [Related]  

  • 34. [Lipolytic activity of kidney tissue in experimental nephrotic syndrome].
    Leĭtes SM; Nikiforova NV
    Vopr Med Khim; 1967; 13(4):404-8. PubMed ID: 5598540
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum lipids in nephrotic syndrome.
    Banerjee SK; Sarkar AK; Chugh KS; Bansal VK; Chhuttani PN
    J Assoc Physicians India; 1972 Sep; 20(9):651-8. PubMed ID: 4654886
    [No Abstract]   [Full Text] [Related]  

  • 36. Astragalus mongholicus and Angelica sinensis compound alleviates nephrotic hyperlipidemia in rats.
    Li J; Yu L; Li N; Wang H
    Chin Med J (Engl); 2000 Apr; 113(4):310-4. PubMed ID: 11775225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of hyperlipidemia with probucol suppresses the development of focal and segmental glomerulosclerosis in chronic aminonucleoside nephrosis.
    Hirano T; Morohoshi T
    Nephron; 1992; 60(4):443-7. PubMed ID: 1584321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperlipidaemia of the nephrotic syndrome--the search for a nephrotic factor.
    Joven J; Vilella E
    Nephrol Dial Transplant; 1995; 10(3):314-6. PubMed ID: 7792024
    [No Abstract]   [Full Text] [Related]  

  • 39. Rationale and management of hyperlipidemia of the nephrotic syndrome.
    Grundy SM; Vega GL
    Am J Med; 1989 Nov; 87(5N):3N-11N. PubMed ID: 2486542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Management of patients with nephrotic syndrome].
    Kohmann A; Graczyk M
    Wiad Lek; 2016; 69(5):703-706. PubMed ID: 28033589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.